FACTFLOW

Monday, 10 August 2026 · Global Edition · Updated 15:25 CST
Business

MaxCyte outlines $30M–$32M 2026 revenue target as ExPERT DTx launch and SPL milestones drive outlook

Business

Apogee Therapeutics prices upsized $350M offering at $70 a share

Business

OpenAI secures more funding, lifting record round to $120B, CFO says

Business

Portofino Resources appoints Rodney Campbell as interim CEO

Business

Arm stock jumps 8% as CEO Haas issues $15B revenue expectation for new chip

Business

Google DeepMind teams up with Agile Robots for AI robotics push

Business

Australian inflation eases to 3.7% in February, beating forecasts; policy outlook stays uncertain

Business

Merck close to $6B acquisition of Terns Pharma to boost cancer portfolio: FT

Business

Kb Home outlines shift to 70% built-to-order deliveries for stronger H2 2026 margins amid market uncertainty

Business

Absci outlines $25B annual market potential for ABS-201 in AGA and advances endometriosis clinical program

Business

BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit

Business

California risks fuel crisis unless Middle East war eases, Chevron executive warns

Business

Energy shortages could ​hit Europe by next month, Shell CEO says

Business

Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation

Business

Crude oil slides as U.S. reportedly has sent proposal to Iran to end Middle East war

Prev 1 480 481 482 483 484 485 486 692 Next